Summary
CVS Health Corporation (CVS) has filed a Current Report on Form 8-K on November 1, 2023, primarily to furnish a press release announcing their financial results for the third quarter ended September 30, 2023. This filing serves as notification to investors about the release of this important financial information, which is detailed in the accompanying press release (Exhibit 99.1). Investors should refer to the press release for specific details regarding CVS Health's performance, including revenue, earnings, and any forward-looking guidance. The 8-K itself does not contain the detailed financial figures but directs stakeholders to the press release for a comprehensive overview of the company's operational and financial condition as of the reporting period. It's important to note the disclaimer that the information furnished is not deemed 'filed' for regulatory purposes, meaning it doesn't carry the same liabilities as a formally filed document under specific sections of the Exchange Act.
Key Highlights
- 1CVS Health announced its third-quarter 2023 financial results via a press release filed with the 8-K.
- 2The 8-K filing's primary purpose is to furnish this press release (Exhibit 99.1) to the SEC.
- 3Investors need to consult the furnished press release for detailed financial performance data for the quarter ended September 30, 2023.
- 4The filing occurred on November 1, 2023.
- 5The information furnished in the 8-K is not considered 'filed' for Section 18 of the Exchange Act, limiting liability.
- 6The report includes a cover page XBRL interactive data file.